
Sign up to save your podcasts
Or


Anticoagulation for embolic stroke of unknown origin, added-sugar labels, AF-patient knowledge, LDL-C and hemorrhagic stroke, and genetic signals in cancer-care cardiomyopathy are discussed this week.
By Medscape4.9
862862 ratings
Anticoagulation for embolic stroke of unknown origin, added-sugar labels, AF-patient knowledge, LDL-C and hemorrhagic stroke, and genetic signals in cancer-care cardiomyopathy are discussed this week.

1,874 Listeners

318 Listeners

542 Listeners

708 Listeners

507 Listeners

167 Listeners

14 Listeners

16 Listeners

3,379 Listeners

138 Listeners

1,141 Listeners

65 Listeners

520 Listeners

367 Listeners

60 Listeners

25 Listeners

7 Listeners

261 Listeners

440 Listeners

274 Listeners